Cardinal Health (CAH) 10-K Summary — Year Ended Jun 30, 2024
The company describes itself as a distributor of pharmaceutical and medical products. For the fiscal period covered, revenue and net income were reported at the levels shown in the supplied metrics.
Key takeaway
Year ended Jun 30, 2024 · FY2025 10-K
The company describes itself as a distributor of pharmaceutical and medical products. For the fiscal period covered, revenue and net income were reported at the levels shown in the supplied metrics.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$226.8B
Revenue reported for the fiscal year.
Operating income
$1.2B
Income from operations reported for the year.
Net income
$852M
Net income reported for the year.
Operating cash flow
$3.8B
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2023 | $54.7B | n/a |
| Dec 31, 2023 | $57.4B | +5.1% |
| Mar 31, 2024 | $54.9B | -4.5% |
| Jun 30, 2024 | $226.8B | +313.4% |
Business overview
Cardinal Health is a healthcare services and products company. It operates as a distributor of pharmaceuticals and medical supplies, serving hospitals, pharmacies, and other healthcare providers. The filing does not provide further segment-level detail beyond this general description.
Financial performance
Revenue for the year was reported at the figure supplied. Operating income and net income were also reported, with net income being lower than operating income. A quarterly trend table shows revenue in an earlier quarter, a subsequent increase, a later decline, and then a large rise in the final quarter, though the filing does not explain the cause of that final increase.
Material risks
The filing references a risk factors section and a cybersecurity section, but no specific risk details are supplied in the text. No material risks beyond those general headings can be identified from the given context.
Liquidity and capital
The company states it believes it has adequate capital resources from available funds and projected cash flow to support operations. In the period, it used cash for debt repayments, share repurchases, capital expenditures, dividends, and a cash acquisition, while also issuing new long-term debt.
What to watch
Monitor the outcome and future cash requirements related to the National Opioid Settlement Agreement, as payments under this agreement affected operating cash flow in the reported period.